14^th Euro Breast Cancer and Therapeutics

Dr Indira Poola has completed her Postdoctoral Fellowship from University of Michigan in 1983. She is currently a scientist in Silbiotech, Inc. Her scientific work is on the subject “ Breast Hyperplasia Risk Signature and Breast Cancer ”

Breast Cancer

Dr. Wiseman is Clinical Professor of Medicine at the Division of Medical Oncology, Keck-USC School of Medicine, and previously was Acting Chief of the Division of Oncology/Hematology at White Memorial Medical Center. Dr. Wiseman has been cited in US News Top Doctors yearly since 2002. He brings more than 40 years of academic and clinical experience to BriaCell Therapeutics Corp. As Co-Founder of BriaCell, he is the inventor for most of the Company’s intellectual property and actively participates in its ongoing technology development. As the former Director of the Breast Cancer Basic Research Laboratory at the University of Texas M.D. Anderson Hospital in the 1970s, he was one of the pioneers of the field of cancer vaccine therapeutics. He has written in over 100 peer-reviewed publications and medical textbook chapters.

oncology, tumor immunology, vaccine development, and genetics

Dr. Mohamed Fathy Ragab is a consultant radiologist who has completed his graduation in Zagazig Univeristy, Egypt. He then conducted post-graduate studies in Tanta Univeristy, Egypt. He also completed his clinical fellowship in diagnostic radiology. Dr. Ragab completed his PET/CT training in Imperial College, London, UK in 2010. As a pioneer in Molecular Imaging and PET/CT scanning in Egypt, Dr. Ragab has joined many PET/CT unites of specialized oncology centers; including International Medical Center, Maadi Military Medical complex and Al-Galaa Military Medical Complex; in-addition to his working in Agouza hospital and PET/CT unit of TechnoScan Radiology centers’ chain. His name appears on many articles that were published in both National and International Journals. Currently, he is engaged in research studies about Role of PET/CT and Molecular Imaging in Management of Cancer Patients in collaboration with Banha University, Egypt.

PET/CT and Molecular Imaging in detection, staging and re-staging of Cancer, as well as therapy monitoring and prediction of therapeutic response in Cancer patients.

Gamal EL-Sayed El-Araby Abdelhameed is Vice manager of administration of medical laboratories at Health affairs directorates, Ministry of Health in Egypt. He obtained a PhD in 2014 on “Early detection of Breast Cancer” in Egyptian women and how to make biostatistics for the epidemiology of breast cancer in women in all Egypt . He holds various positions which includes Medical Analysis Specialist, Manager of microbiology lab & Responsible for water treatment units, Researcher, Medical Representative

Pharmacy and medical supply, chemistry and biology, scientific researcher, disaster risk reduction, crisis and conflict prevention, mitigation, resolution and reconciliation

Dr.Ghina Berjawi completed her MD and Diagnostic Radiology residency at the American University of Beirut, Lebanon. She then completed her Clinical Fellowship in Breast Imaging and Intervention at King’s College Hospital, London, and MD Anderson Cancer Center, followed by a Clinical Fellowship in MR and Transvaginal Ultrasound Imaging and Interventional Radiology of the Female Genital Tract at Centre Hospitalier Universitaire de Limoges, France. She is also a Fellow of The Royal College of Radiologists (FRCR), London, since 2009. She is currently an Associate Professor of Clinical Diagnostic Radiology and director of the Mamdouha Sayed Bobst Breast Unit at the American University of Beirut Medical Center. Her name appears on over 40 original articles and abstracts, and she has presented at various national and international conferences

Breast Imaging, Women’s Imaging

Professor Charles Coombes, Professor of Medical Oncology, Imperial College London. He is also Hon Consultant Medical Oncologist, Imperial College Healthcare Trust.From October 2010 Professor Coombes is Director of The Imperial CRUK Cancer Centre. He is also Chair of The Imperial Cancer Research (UK) Centre Steering Committee and Theme leader for Cancer, Imperial College London He is engaged in developing novel methods for prediction of response to endocrine therapy in breast cancer and also carrying out research aimed at understanding the mechanisms of resistance to endocrine therapy and development of novel anti-cancer drugs

molecular signals controlling aberrant growth of breast cancer cells with specific focus on the oestrogen receptor and allied cell signalling pathways

Professor Charles Coombes, Professor of Medical Oncology, Imperial College London. He is also Hon Consultant Medical Oncologist, Imperial College Healthcare Trust.From October 2010 Professor Coombes is Director of The Imperial CRUK Cancer Centre. He is also Chair of The Imperial Cancer Research (UK) Centre Steering Committee and Theme leader for Cancer, Imperial College London.

He is engaged in developing novel methods for prediction of response to endocrine therapy in breast cancer and also carrying out research aimed at understanding the mechanisms of resistance to endocrine therapy and development of novel anti-cancer drugs.

In his capacity as Head of Division of Cancer until 30 September 2012, he was responsible for the running of the division, as well as the recruitment and retention of staff. He is personally responsible for running the section of Cancer Cell Biology and has three CRUK Programme Grants and many other project and smaller grants. This department currently has more than 280 scientific staff. The department has doubled in size over the past three years and now has and I4 Professors and twenty sections.

His laboratory is focusing on elucidating molecular signals controlling aberrant growth of breast cancer cells with specific focus on the oestrogen receptor and allied cell signalling pathways. He works with scientists engaged in molecular target identification and chemists whose remit is to target specific signalling abnormalities to develop novel therapies for breast cancer. He also runs a translational laboratory which focuses on detection of micrometastatic disease and application to the treatment of breast cancer. He is Chairman of the International Collaborative Cancer Group. This is a multinational trial centre which is based within Imperial College focussing on phase II and phase III studies in breast cancer.

molecular signals controlling aberrant growth of breast cancer cells with specific focus on the oestrogen receptor and allied cell signalling pathways

Dr. Mohamed Fathy Ragab is a consultant radiologist who has completed his graduation in Zagazig Univeristy, Egypt. He then conducted post-graduate studies in Tanta Univeristy, Egypt. He also completed his clinical fellowship in diagnostic radiology. Dr. Ragab completed his PET/CT training in Imperial College, London, UK in 2010. As a pioneer in Molecular Imaging and PET/CT scanning in Egypt, Dr. Ragab has joined many PET/CT unites of specialized oncology centers; including International Medical Center, Maadi Military Medical complex and Al-Galaa Military Medical Complex; in-addition to his working in Agouza hospital and PET/CT unit of TechnoScan Radiology centers’ chain. His name appears on many articles that were published in both National and International Journals. Currently, he is engaged in research studies about Role of PET/CT and Molecular Imaging in Management of Cancer Patients in collaboration with Banha University, Egypt.

PET/CT and Molecular Imaging in detection, staging and re-staging of Cancer, as well as therapy monitoring and prediction of therapeutic response in Cancer patients.

Dr Leandro Castellano is Senior Lecturer in Biochemistry at the University of Sussex in Brighton, and honorary Senior Lecturer at Imperial College London (UK). He obtained a PhD in 2007 at the University “La Sapienza”, Rome, working on the role of microRNAs in solid and liquid cancers. He then moved to Imperial College the same year where he identified for the first time that microRNAs can be regulated by oestrogen receptor alpha (ER-alpha) in ER positive breast cancer which in turn, modulate ER-alpha itself. This regulative miRNA-mRNA network forms a negative feedback loop crucial for breast cancer progression. His research interest focuses on the role of short and long non-coding RNAs in the progression of breast, pancreatic and other solid cancers. He published several articles reporting finding on the role of non-coding RNAs in these diseases using high-throughput sequencing technologies for global discoveries.

Solid cancer, non-coding RNA, gene expression, biological networks in cancer

Gamal EL-Sayed El-Araby Abdelhameed is Vice manager of administration of medical laboratories at Health affairs directorates, Ministry of Health in Egypt. He obtained a PhD in 2014 on “Early detection of Breast Cancer” in Egyptian women and how to make biostatistics for the epidemiology of breast cancer in women in all Egypt . He holds various positions which includes Medical Analysis Specialist, Manager of microbiology lab & Responsible for water treatment units, Researcher, Medical Representative

Pharmacy and medical supply, chemistry and biology, scientific researcher, disaster risk reduction, crisis and conflict prevention, mitigation, resolution and reconciliation

Dr. Bhattacharjee did her B.Sc in Biotechnology from Bangalore University in 2006 and M.Sc in Applied Genetics from Bangalore University in 2008. She then moved to England to pursue her DPhil (Phd) in Biochemistry from Oxford University where she studied the role of Fml1 and its partner proteins Mhf1 and Mhf2 in promoting genome stability. She was awarded her DPhil in 2012. During her time at Oxford, she was also a tutor at Greene’s College, Oxford. In 2013, Dr. Bhattacharjee moved to Cold Spring Harbor Laboratory, New York. At CSHL, her work has focused on understanding the epigenetic regulation of DNA repair. She is also an academic tutor at the Watson School of Biological studies, the school for graduate studies at CSHL

Bio chemistry

Professor Fleming is a direct descendant of Rollo. He was born in Cedar Falls, IA and received his Doctorate in Particle Physics through the JFK administration. He has additional degrees in Biology, Chemistry, Psychology, Medicine and Law. He is specifically trained as a Nuclear and Preventive Cardiologist in addition to Nuclear Imaging. He is one of three Physicians in the world Certified in PET Imaging and the only American. He is the founder of the theory of "Inflammation and Heart Disease" and is considered by many to be the Father of Modern Nuclear Cardiology and Nuclear Medicine since his development of the first truly quantitative AI system for detection and treatment monitoring of Heart Disease & Cancer. He has published more than 150 papers in the field, reviews for more than a dozen peer reviewed medical journals, has published three books, 8 chapters in medical textbooks and been Editor-in-Chief of the medical textbook "Establishing Better Standards of Care in Doppler Echocardiography, Computed Tomography and Nuclear Cardiology."

Heart Disease, Cancer, Nuclear Cardiology, Nuclear Medicine

Dr Silvia Paola Corona has completed her PhD from Melbourne University (Australia). Silvia Paola is currently a medical doctor/researcher at the Breast Surgery Division of the European Institute of Oncology, in Milan, a wordly renowned institute. She has published papers and served as reviewer in international peer-reviewed journals.

Breast Cancer surgery, targeted therapies and genetics.

Dr Kyriakos Kalogerakos has completed his Degree in Medical School from the Aristotle University Thessaloniki in June 1986. He is currently a Director and Chairman of Breast Unit of Metaxa Hospital.`His scientific work is on the subject “ The behavior of cancer markers in blood serum and bile in neoplasms of the gastrointestinal tract ”

Breast cancer

ACHOUR Radhouane is associate professor at faculty of medicine of Tunis-Tunisia; He has published many basic and clinical articles in relation to gynecology and obstetrics. , his research interests include Rare Diseases in gynecology and prenatal diagnosis. He serves as associate professor, Emergency Department of Gynecology and Obstetrics in maternity and neonatology center Tunis Tunisia. He also serves as member of the editorial team for: Asian Pacific Journal of Reproduction, the Global Journal of Rare Diseases, Journal of Neonatal Biology, Current pediatric research, Obstetrics and Gynecology: Open access, Pediatrics and Health Research and Member of the Science Advisory Board.

Breast Pathology, Reproductive Medicine, Gynecology

Dr.Eman Almohawes,is consultatnt diagnostic radiology and women's imaging ,Head of medical imaging department at security forces hospital Dammam Saudi Arabia. As one of the leading figures advocating for early detection and screening of breast cancer for women in Saudi Arabia Eastern province at Saudi cancer foundation , she was the honorary chairperson of the early detection breast cancer campaign 2017 till present organized at May aljaber early cancer detection center. Founder of breast cancer screening program at security forces hospital Dammam established in 2017. Honored for participating and valuable contribution as organizer and speaker in the success of women health and imaging conferences as well as cancer conferences. Honored by Saudi Minister of Health Dr.Tawfeeq AlRabiya for the volunteer participation and work in breast screening at Saudi cancer foundation on international volunteer day 5th /Dec/2017. Member of European society of breast imaging 2018(EUSOBI).

Breast Imaging

Dr.Ghina Berjawi completed her MD and Diagnostic Radiology residency at the American University of Beirut, Lebanon. She then completed her Clinical Fellowship in Breast Imaging and Intervention at King’s College Hospital, London, and MD Anderson Cancer Center, followed by a Clinical Fellowship in MR and Transvaginal Ultrasound Imaging and Interventional Radiology of the Female Genital Tract at Centre Hospitalier Universitaire de Limoges, France. She is also a Fellow of The Royal College of Radiologists (FRCR), London, since 2009. She is currently an Associate Professor of Clinical Diagnostic Radiology and director of the Mamdouha Sayed Bobst Breast Unit at the American University of Beirut Medical Center. Her name appears on over 40 original articles and abstracts, and she has presented at various national and international conferences

Breast Imaging, Women’s Imaging.